Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
IO Biotech, Inc. (IOBT) had Stock-Based Compensation of $6.53M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-95.49M |
|
-- |
|
-- |
|
$95.18M |
|
$-95.18M |
|
$1.13M |
|
$-94.05M |
|
$-94.05M |
|
$-95.49M |
|
$-95.49M |
|
$-95.49M |
|
$-95.49M |
|
$-95.18M |
|
$-94.92M |
|
65.88M |
|
65.88M |
|
$-1.45 |
|
$-1.45 |
|
| Balance Sheet Financials | |
$64.95M |
|
$0.64M |
|
$2.75M |
|
$67.70M |
|
$19.49M |
|
-- |
|
$1.20M |
|
$20.68M |
|
$47.02M |
|
$47.02M |
|
$47.02M |
|
65.88M |
|
| Cash Flow Statement Financials | |
$-82.35M |
|
$-0.04M |
|
-- |
|
$143.46M |
|
$60.30M |
|
$-83.16M |
|
|
Stock-Based Compensation |
$6.53M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-82.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-203.11% |
|
-203.11% |
|
-141.05% |
|
-203.11% |
|
$0.71 |
|
$-1.25 |
|
$-1.25 |
|